Real-world evaluation of vascular complications and comorbidities in Portuguese patients with type 2 diabetes: Results from the cMORE study

被引：0
|
作者：
Bronze, Luis [1 ,2 ]
机构：
[1] Portuguese Navy, Lisbon, Portugal
[2] Beira Interior Univ, Cardiovasc Med, Covilha, Portugal
来源：
REVISTA PORTUGUESA DE CARDIOLOGIA | 2024年 / 43卷 / 12期
关键词：
D O I：
10.1016/j.repc.2024.08.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：681 / 683
页数：3
相关论文
共 50 条
  • [41] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Tanaka, Kenichi
    Okada, Yosuke
    Tokutsu, Akemi
    Tanaka, Yoshiya
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [42] Hospital treatment costs associated with incident complications in patients with type 2 diabetes—real-world study based on electronic patient information systems
    Reijo Sund
    Tuomas Peltonen
    Aku-Ville Lehtimäki
    Janne Martikainen
    BMC Health Services Research, 22
  • [43] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Kenichi Tanaka
    Yosuke Okada
    Akemi Tokutsu
    Yoshiya Tanaka
    Scientific Reports, 12
  • [44] Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
    Patti, Angelo Maria
    Giglio, Rosaria Vincenza
    Allotta, Alberto
    Bruno, Andreina
    Di Bella, Tommaso
    Stoian, Anca Pantea
    Ciaccio, Marcello
    Rizzo, Manfredi
    BIOMEDICINES, 2023, 11 (05)
  • [45] Analysis of the duration and extent of the legacy effect in patients with type 2 diabetes: A real-world longitudinal study
    Takao, Toshiko
    Matsuyama, Yutaka
    Suka, Machi
    Yanagisawa, Hiroyuki
    Kasuga, Masato
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (08) : 516 - 522
  • [46] Impact of Initial Treatment Policies on Long-term Complications and Costs in Japanese Patients with Type 2 Diabetes: A Real-World Database Study
    Yoshihara, Hiroshi
    Tonoike, Tohru
    Ohno, Hiromitsu
    Nishiuchi, Susumu
    Igarashi, Ataru
    DIABETES THERAPY, 2024, 15 (08) : 1811 - 1820
  • [47] Basal Insulin Dose Titration for Glycemic Control in Patients With Type 2 Diabetes Mellitus in Thailand: Results of the REWARDS Real-World Study
    Deerochanawong, Chaicharn
    Leelawattana, Rattana
    Kosachunhanun, Natapong
    Tantiwong, Puntip
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2020, 13
  • [48] VASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES: PREVALENCE AND COMORBIDITIES IN 6 COUNTRIES OF LATIN AMERICA (A COHORT OF THE DISCOVER STUDY PROGRAM)
    Chen-Ku, Chih H.
    Gonzalez-Galvez, Guillermo
    Vasquez, Martin
    Fuente, Graciela
    Nakazone, Marcelo Arruda
    Silva Giordano, Alejandra L.
    de Sa Pereira, Marcelo Horacio
    ENDOCRINE PRACTICE, 2019, 25 (10) : 994 - 1002
  • [49] Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register
    Lim, Lee-Ling
    Lau, Eric S. H.
    Cheung, Johnny T. K.
    Chan, Siew Pheng
    Ji, Linong
    Lim, Soo
    Sirinvaravong, Sirinart
    Unnikrishnan, A. G.
    Luk, Andrea O. Y.
    Cortese, Viviana
    Durocher, Alexandra
    Chan, Juliana C. N.
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 208 - 221
  • [50] The Impact of Comorbidities and Clinical Characteristics on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study
    Chupp, G. L.
    Heaney, L. G.
    Pelaia, G.
    Welte, T.
    Sanchez, C. Almonacid
    Lee, J. K.
    Maxwell, A.
    Price, R. G.
    Jakes, R. W.
    Cristancho, R. Alfonso
    Howarth, P.
    Brusselle, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345